This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Matthews, D. R Articles by Wallace, T. M Search for Related Content Social Bookmarking                         What's this?

Review: Sulphonylureas and the rise and fall of beta-cell function

Oxford Centre for Diabetes, Endocrinology and Metabolism, The Churchill Hospital, Headington, Oxford, OX3 7LJ, UK

Tara M Wallace

david.matthews{at}ocdem.ox.ac.uk

Sulphonylureas are an accepted and widely used treatment for hyperglycaemia in type 2 diabetes. The UK Prospective Diabetes Study (UKPDS) demonstrated that, like other oral agents used in clinical practice, there are early good results which fail over time. Conclusions drawn show that it is in fact a result of progressive loss of beta-cell function. Results from the UKPDS and several other studies reinforce the need for ongoing and tailored treatment to maintain glycaemic control and slow symptom progression. So sulphonylureas improve beta-cell function in those with type 2 diabetes over many years, but their effects are lessened by progressive beta-cell failure. In the enthusiasm for new therapies they should not be neglected as a mainstay of oral treatment early in the course of type 2 diabetes.

Key Words: sulphonylureas • type 2 diabetes • beta-cell • insulin secretion • insulin resistance.

References

• Janbon M., Chaptal J., Uedel A., Schaap J. Accidents hypoglycaemiques graves par un sulfamide-thiodazole. Communications Soc Sci Med Biol Montpellier 1942:222-50.
• Balant L. Les sulfonylurees hypoglycemiantes: un probleme de generations? Considerations pharmacocinetiques et pharmacodynamiques. Diabet Metab 1978;4:135-43.[Web of Science][Medline] [Order article via Infotrieve]
• Ukpds Group. UK Prospective Diabetes Study 26: Sulphonylurea failure in non-insulin dependent diabetic patients over 6 years. Diabet Med 1998;15:297-303.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Harrower AD Comparison of efficacy, secondary failure rate, and complications of sulfonylureas. J Diabetes Complications 1994;8:201-03.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Wallace TM, Matthews DR Coefficient of failure: a methodology for examining longitudinal beta- cell function in type 2 diabetes. Diabet Med 2002;19:465-9.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-19.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Ukpds Group. UK Prospective Diabetes Study 16: Overview of six years' therapy of type 2 diabetes - a progressive disease. Diabetes 1995; 44:1249-58.[Abstract]
• Cerasi E. Potentiation of insulin release by glucose in man. I. Quantitative analysis of the enhancement of glucose-induced insulin secretion by pretreatment with glucose in normal subjects. Acta Endocrinol (Copenh) 1975;79:483-501.
• Hosker JP, Rudenski AS, Burnett MA, Matthews DR, Turner RC Similar reduction of first- and second-phase B-cell responses at three different glucose levels in type II diabetes and the effect of gliclazide therapy. Metabolism 1989;38:767-72.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Matthews DR, Hosker JP, Stratton I. The physiological action of gliclazide: beta-cell function and insulin resistance. Diabetes Res Clin Pract 1991;14 (suppl 2):S53-S59.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Matthews D., Boland O. The stimulation of insulin secretion in non-insulin-dependent diabetic patients by amino acids and gliclazide in the basal and hyperglycemic state. Metabolism 1997;46(suppl 1):5-9.[Web of Science][Medline] [Order article via Infotrieve]
• Matthews D., Hosker J., Turner R. Effects of gliclazide on insulin secretion induced by glucose and amino acids. International Diabetes Federation Bulletin 1987;32:12-15.
• Kahn SE, Prigeon RL, McCulloch DK et al. Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-72.[Abstract]
• Wallace TM, Levy JC, Matthews DR An increase in insulin sensitivity and basal beta-cell function in diabetic subjects treated with pioglitazone in a placebo-controlled randomized study. Diabet Med 2004;21:568-76.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Schernthaner G., Matthews DR, Charbonnel B., Hanefeld M., Brunetti P. Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial. J Clin Endocrinol Metab 2004;89:6068-76.[Abstract/Free Full Text]
• Ashcroft FM, Rorsman P. Electrophysiology of the pancreatic beta-cell. Prog Biophys Mol Biol 1989;54:87-143.[CrossRef][Medline] [Order article via Infotrieve]
• Aguilar-Bryan L., Nichols CG, Wechsler SW et al. Cloning of the beta cell high-affinity sulfonylurea receptor: a regulator of insulin secretion. Science 1995;268:423-6.[Abstract/Free Full Text]
• Ashcroft FM Mechanisms of the glycaemic effects of sulphonylureas. Horm Metab Res 1996;28:456-63.[Web of Science][Medline] [Order article via Infotrieve]
• Fuhlendorff- J., Rorsman- P., Kofod- H. et al. Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes. Diabetes 1998;47:345-51.[Abstract]
• Gribble FM, Ashcroft FM Differential sensitivity of beta-cell and extrapancreatic K(ATP) channels to gliclazide. Diabetologia 1999;42:845-8.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Meier JJ, Gallwitz B., Schmidt WE, Mugge A., Nauck MA Is impairment of ischaemic preconditioning by sulfonylurea drugs clinically important? Heart 2004;90(1):9-12.[Abstract/Free Full Text]
• Meinert CL, Knatterud GL, Prout TE, Klimt CR A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results. Diabetes 1970;19(suppl):789-830.[Web of Science][Medline] [Order article via Infotrieve]
• Schwartz TB, Meinert CL The UGDP controversy: thirty-four years of contentious ambiguity laid to rest. Perspect Biol Med 2004;47:564-74.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Tattersall RB, Fajans SS A difference between the inheritance of classical juvenile-onset and maturity-onset type diabetes of young people. Diabetes 1975;24(1):44-53.[Abstract]
• Froguel P., Vaxillaire M., Sun F. et al. Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus. Nature 1992;356:162-4.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]
• Hattersley AT, Turner RC, Permutt MA et al. Linkage of type 2 diabetes to the glucokinase gene. Lancet 1992;339:1307-10.[CrossRef][Web of Science][Medline] [Order article via Infotrieve]

The British Journal of Diabetes & Vascular Disease, Vol. 5, No. 4, 192-196 (2005)
DOI: 10.1177/14746514050050040301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				G. Alberti Tight glycaemic control: the key to improving the management of type 2 diabetes The British Journal of Diabetes & Vascular Disease, July 1, 2005; 5(4): 184 - 185. [PDF]

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Matthews, D. R Articles by Wallace, T. M Search for Related Content Social Bookmarking                         What's this?